Conceptio
›
Archive
›
NCBI PubMed Central
NCBI PubMed Central
open access
Drug response profile-based machine learning enables strategic cell line and compound selection for drug development.
Abdel-Rehim A et al.
NCBI PubMed Central · Papers · License: Open Access
Open Source ↗
Direct PDF ↓
machine learning systems
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗
Related documents
State-of-the-art and future developments in dosimetry for SSTR- and PSMA-targeting radioligand therapies.
#1016098
American Association for Thoracic Surgery Quality Gateway: A surgeon case study of its application in adult cardiac surgery for quality assurance.
#1016099
Metabolic Reprogramming of Cancer Stem Cells: Targeting Lipid Flux and Mitochondrial Plasticity to Overcome Therapeutic Resistance.
#1016100
Symptom Bother Is Associated With Medical Care‐Seeking for LUTS in Japanese Women: A Survey of 1800 Women.
#1016101
Record
· ID 266897
Retrieved via
Conceptio
— every document is proof-bundled with source, license, and retrieval metadata.